Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Shaolin Tao"'
Publikováno v:
BMC Medical Genomics, Vol 13, Iss 1, Pp 1-8 (2020)
Abstract Background Multifocal lung cancers (MLCs) are common in patients newly diagnosed with lung cancer, and histological results of most synchronous MLCs are similar. Few cases with different histology findings have been reported, and no genomic
Externí odkaz:
https://doaj.org/article/eefd4f9da30247639bf6470065af77ae
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2021 (2021)
Journal of Oncology, Vol 2021 (2021)
Reduced sensitivity to chemotherapeutic drugs is almost inevitable in lung adenocarcinoma patients. Thus, understanding the relevant mechanisms is urgent. Positive cofactor 4 (PC4) was at first revealed to be a coactivator of basal transcription. Pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c011e96c8197bf4f34444c3c7b50a68a
https://doi.org/10.1155/2021/9958483
https://doi.org/10.1155/2021/9958483
Autor:
Bo Deng, Tan Long, Hua Jin, Sha-Sha Jiang, Qunyou Tan, Shaolin Tao, Bin Jiang, Xiao-yang Wang, Chun-Guo Mao, Yan-Lian Yang, Yi Huang, Cheng-Yi Mao, Zhi-Yuan Hu
Publikováno v:
International Journal of Biological Sciences
Background: We investigated the roles of breast cancer anti-estrogen resistance 1 (BCAR1/p130Cas) in the formation and immunoevasion of invasive circulating tumor cells (CTCs) in lung adenocarcinoma (LUAD). Methods: Biomarkers of CTCs including BCAR1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5307dc64f7d43709821b14c0420d1f69
http://europepmc.org/articles/PMC8315020
http://europepmc.org/articles/PMC8315020
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Circulating tumor cells (CTCs) can be clustered into three subtypes according to epithelial-mesenchymal transition (EMT) markers: CTCs with epithelial markers (E-CTCs), CTCs with mesenchymal markers (M-CTCs), and CTCs with both markers (E&
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc50adc3a077bf2c516a8fe1355161b
https://doi.org/10.12998/wjcc.v9.i12.2721
https://doi.org/10.12998/wjcc.v9.i12.2721
Publikováno v:
Thoracic Cancer. 12:1558-1569
Background Recurrence is a major challenge in early-stage lung adenocarcinoma (LUAD) treatment. Here, we investigated the role and mechanism of high-mobility group AT-hook 1 (HMGA1) and glucose-regulated protein 75-kDa (GRP75) in stage I LUAD and eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79c75bfb3319c4a2742a4247eb4c30e2
https://doi.org/10.1111/1759-7714.13944
https://doi.org/10.1111/1759-7714.13944
Publikováno v:
BMC Medical Genomics, Vol 13, Iss 1, Pp 1-8 (2020)
BMC Medical Genomics
BMC Medical Genomics
Background Multifocal lung cancers (MLCs) are common in patients newly diagnosed with lung cancer, and histological results of most synchronous MLCs are similar. Few cases with different histology findings have been reported, and no genomic or transc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::916cbac4a8b5d8aee55b858b08c133a7
https://doaj.org/article/eefd4f9da30247639bf6470065af77ae
https://doaj.org/article/eefd4f9da30247639bf6470065af77ae
Autor:
Hongming Liu, Jie Yang, Tingting Wang, Shaolin Tao, Cailing Zhong, Jingqing Zhang, Chunshu Fang, Mingjun Wu, Yun Chen, Qunyou Tan, Kailing Li
Publikováno v:
Nanoscale. 13(35)
The discovery of effective anticancer drug delivery systems and elucidation of the mechanism are enormous challenges. Using two drug administration-approved biomaterials, we constructed a natural medicine (NM)-loaded ternary supramolecular nanocomple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e90033178135cea563f088c9741550b
https://pubmed.ncbi.nlm.nih.gov/34533154
https://pubmed.ncbi.nlm.nih.gov/34533154
Purpose: PC4 is a novel marker for diagnosis and treatment of advanced human cancers metastasis. This study aimed to verify that high expression of PC4 is associated with lymphatic metastasis and predicts poor prognosis in lung adenocarcinoma probabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7ed63ba6ea53036977ab764d81135e7
https://doi.org/10.21203/rs.3.rs-761143/v1
https://doi.org/10.21203/rs.3.rs-761143/v1
Publikováno v:
Molecular Therapy Oncolytics
Even with optimal surgery, many early-stage non-small cell lung cancer (NSCLC) patients die of recurrence. Unfortunately, there are no precise predictors for postoperative recurrence in early-stage NSCLC, and the recurrence mechanism is still unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e02236ad3f21d642decebb89cb3f680
https://pubmed.ncbi.nlm.nih.gov/35071744
https://pubmed.ncbi.nlm.nih.gov/35071744
Background: Recurrence is a major challenge in early-stage lung adenocarcinoma (LUAD) treatment. However, the recurrence mechanism is still unclear, and no biomarkers can predict recurrence in early-stage LUAD. Here, we investigated the role and mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8239fa5b142d617235736168a19e3a
https://doi.org/10.21203/rs.3.rs-122104/v1
https://doi.org/10.21203/rs.3.rs-122104/v1